| meta-analysis | Q815382 |
| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1345/APH.1E576 |
| P698 | PubMed publication ID | 15855241 |
| P2093 | author name string | Chutamanee Suthisisang | |
| Nalinee Poolsup | |||
| Patchareeya Channark | |||
| Wararat Kittikulsuth | |||
| P2860 | cites work | Meta-analysis in clinical trials | Q27860779 |
| Assessing the quality of reports of randomized clinical trials: is blinding necessary? | Q27860973 | ||
| Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis | Q28374250 | ||
| The number needed to treat: a clinically useful measure of treatment effect | Q29619672 | ||
| Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial | Q32050561 | ||
| Beyond disability: measuring the social and personal consequences of osteoarthritis | Q33604673 | ||
| Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate | Q33651430 | ||
| Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee | Q33727275 | ||
| A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee | Q34122293 | ||
| Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis | Q34214244 | ||
| Nutripharmaceuticals for osteoarthritis | Q34376742 | ||
| Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro. | Q34503637 | ||
| Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis | Q34510491 | ||
| Sulfate could mediate the therapeutic effect of glucosamine sulfate | Q34516115 | ||
| Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee | Q34517615 | ||
| Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study | Q34528067 | ||
| Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: evidence from two 3-year studies | Q34546341 | ||
| Glucosamine and chondroitin sulfate are effective inthe management of osteoarthritis | Q35121454 | ||
| Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis. | Q35692131 | ||
| Correlation between radiographic severity of knee osteoarthritis and future disease progression. Results from a 3-year prospective, placebo-controlled study evaluating the effect of glucosamine sulfate. | Q40613208 | ||
| Variability in knee radiographing: implication for definition of radiological progression in medial knee osteoarthritis. | Q43053545 | ||
| Glucosamine: con or cure? | Q44014713 | ||
| Glucosamine sulfate in osteoarthritis of the knee. | Q53017997 | ||
| Distribution Theory for Glass's Estimator of Effect size and Related Estimators | Q56016631 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | osteoarthritis | Q62736 |
| systematic review | Q1504425 | ||
| knee osteoarthritis | Q1777118 | ||
| glucosamine | Q32907954 | ||
| P304 | page(s) | 1080-1087 | |
| P577 | publication date | 2005-04-26 | |
| P1433 | published in | Annals of Pharmacotherapy | Q4767858 |
| P1476 | title | Glucosamine long-term treatment and the progression of knee osteoarthritis: systematic review of randomized controlled trials | |
| P478 | volume | 39 |
| Q36492429 | A natural mineral supplement provides relief from knee osteoarthritis symptoms: a randomized controlled pilot trial. |
| Q37097578 | A natural seaweed derived mineral supplement (Aquamin F) for knee osteoarthritis: a randomised, placebo controlled pilot study |
| Q37850240 | A review of the evaluation and management of cartilage defects in the knee |
| Q34655436 | Chondroitin and glucosamine in the management of osteoarthritis: an update |
| Q38215383 | Chondroprotection and the prevention of osteoarthritis progression of the knee: a systematic review of treatment agents. |
| Q24602794 | Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT |
| Q45797653 | Combination of glucosamine improved therapeutic effect of low-dose cyclosporin A in patients with atopic dermatitis: a pilot study |
| Q84649749 | Complementary and Alternative Medicines: Clinical Pearls for Commonly Used Dietary Supplements |
| Q50459670 | Effect of oral glucosamine on joint structure in individuals with chronic knee pain: a randomized, placebo-controlled clinical trial. |
| Q35147261 | Effects of Glucosamine and Chondroitin Sulfate on Cartilage Metabolism in OA: Outlook on Other Nutrient Partners Especially Omega-3 Fatty Acids |
| Q43182266 | Effects of chondroitin sulfate and glucosamine in adult patients with Kaschin-Beck disease |
| Q24606203 | Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis |
| Q34345032 | Efficacies of different preparations of glucosamine for the treatment of osteoarthritis: a meta-analysis of randomised, double-blind, placebo-controlled trials |
| Q37354339 | Glucosamine and chondroitin for osteoarthritis |
| Q21195259 | Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis? |
| Q28573980 | Mechanisms of glucosamine-induced suppression of the hepatic assembly and secretion of apolipoprotein B-100-containing lipoproteins |
| Q37798321 | Modern Management of Mild-to-Moderate Joint Pain due to Osteoarthritis: A Holistic Approach |
| Q37663509 | Open-label, randomized, controlled pilot study of the effects of a glucosamine complex on Low back pain |
| Q30863651 | Osteoarthritis of the knee |
| Q33636796 | Perceptions, use and attitudes of pharmacy customers on complementary medicines and pharmacy practice. |
| Q37025257 | Pharmacologic Management of Osteoarthritis-Related Pain in Older Adults: A Review Shows that Many Drug Therapies Provide Small-to-Modest Pain Relief |
| Q38856700 | Prevalence of Glucosamine and Omega-3 Fatty Acid Use and Characteristics of Users among Mid-Age Women: Analysis of a Nationally Representative Sample of 10,638 Women |
| Q80799862 | Readers' and author's responses to "Evidence-based standards should apply to dietary supplements, too" |
| Q34570456 | Risk assessment for glucosamine and chondroitin sulfate |
| Q47147618 | Scientific Opinion on the substantiation of a health claim related to glucosamine hydrochloride and reduced rate of cartilage degeneration and reduced risk of development of osteoarthritis pursuant to Article 14 of Regulation (EC) No 1924/2006 |
| Q33622337 | The Hip and Knee Book: developing an active management booklet for hip and knee osteoarthritis |
| Q31080416 | Who uses glucosamine and why? A study of 266,848 Australians aged 45 years and older |
Search more.